CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 254 filers reported holding CRISPR THERAPEUTICS AG in Q4 2019. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,489,350 | -30.8% | 165,000 | -14.5% | 0.02% | -37.5% |
Q2 2023 | $10,829,406 | -46.8% | 192,900 | -57.2% | 0.03% | -27.3% |
Q1 2023 | $20,367,069 | +15.0% | 450,300 | +3.4% | 0.04% | -12.0% |
Q4 2022 | $17,711,205 | -41.5% | 435,700 | -5.9% | 0.05% | -45.7% |
Q3 2022 | $30,257,000 | +49.7% | 463,000 | +39.2% | 0.09% | +41.5% |
Q2 2022 | $20,206,000 | +35.3% | 332,500 | +39.7% | 0.06% | +38.3% |
Q1 2022 | $14,939,000 | +173.9% | 238,000 | +230.6% | 0.05% | +161.1% |
Q4 2021 | $5,455,000 | -40.0% | 71,993 | -11.4% | 0.02% | -45.5% |
Q3 2021 | $9,098,000 | -29.9% | 81,282 | +1.4% | 0.03% | -35.3% |
Q2 2021 | $12,979,000 | +63.4% | 80,172 | +23.0% | 0.05% | +45.7% |
Q1 2021 | $7,944,000 | +153.2% | 65,200 | +218.0% | 0.04% | +150.0% |
Q4 2020 | $3,138,000 | +207.6% | 20,500 | +68.0% | 0.01% | +180.0% |
Q3 2020 | $1,020,000 | +7.6% | 12,200 | -5.4% | 0.01% | -16.7% |
Q2 2020 | $948,000 | -15.0% | 12,900 | -51.0% | 0.01% | -33.3% |
Q1 2020 | $1,115,000 | -82.3% | 26,300 | -74.5% | 0.01% | -79.1% |
Q4 2019 | $6,287,000 | +133.8% | 103,218 | +57.3% | 0.04% | +95.5% |
Q3 2019 | $2,689,000 | +34.0% | 65,615 | +54.0% | 0.02% | +29.4% |
Q2 2019 | $2,007,000 | +260.3% | 42,600 | +173.1% | 0.02% | +240.0% |
Q1 2019 | $557,000 | -73.0% | 15,600 | -78.4% | 0.01% | -64.3% |
Q4 2018 | $2,063,000 | +1189.4% | 72,191 | +1905.3% | 0.01% | +1300.0% |
Q3 2018 | $160,000 | – | 3,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |